Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Lars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees
63,370
Employees63,370
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1931
Founded1931
Employees
63,370
Employees63,370

NVO Key Statistics

Market cap
470.39B
Market cap470.39B
Price-Earnings ratio
34.34
Price-Earnings ratio34.34
Dividend yield
0.97%
Dividend yield0.97%
Average volume
6.20M
Average volume6.20M
High today
$106.94
High today$106.94
Low today
$104.96
Low today$104.96
Open price
$105.79
Open price$105.79
Volume
3.99M
Volume3.99M
52 Week high
$148.15
52 Week high$148.15
52 Week low
$94.73
52 Week low$94.73

NVO News

The Wall Street Journal 2d
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction

Novo Nordisk CFO Karsten Knudsen said in an interview that the company is encouraged by White House proposals that could support patients using weight-loss drug...

Novo Nordisk Says White House Obesity Plan Is Step in Right Direction
TipRanks 2d
Novo Nordisk Stock Jumps on Biden Weight Loss Proposal Despite Upcoming Trump Presidency

Shares of Danish pharmaceutical company Novo Nordisk (NVO) are getting a 1.63% boost on Tuesday alongside a proposal from President Joe Biden. The President sug...

TipRanks 2d
Weight loss drugmakers in spotlight as White House proposes coverage

The Biden-Harris Administration has proposed a new rule to expand coverage of anti-obesity medications for Americans with Medicare and Medicaid, sending the sha...

Analyst ratings

63%

of 32 ratings
Buy
62.5%
Hold
25%
Sell
12.5%

More NVO News

Benzinga 2d
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs

The Biden-Harris Administration has proposed expanding Medicare and Medicaid coverage for anti-obesity medications, aiming to address the high costs that have d...

Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
TipRanks 3d
Novo Nordisk Launches Major Share Repurchase Program

Novo Nordisk (NVO) has released an update. Don't Miss our Black Friday Offers: Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make sm...

Seeking Alpha 6d
Catalent gains on report it's likely to be granted EU approval for Novo Holdings deal

Catalent (NYSE:CTLT) rose 2% amid a report that the European Union's antitrust regulator will likely grant approval for its planned sale to Novo Holdings, the p...

Catalent gains on report it's likely to be granted EU approval for Novo Holdings deal
Seeking Alpha 7d
Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens

Novo Nordisk’s (NVO) (OTCPK:NONOF) contract with Swiss medical device maker Ypsomed (OTCPK:YPHDF) includes a deal to supply injection pens for Danish drugmaker’...

Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens
Quartz 7d
Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup

Oura smart rings will soon be able to help users track their blood sugar levels through a new partnership with Dexcom (DXCM) , the maker of the U.S.’s first ove...

Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.